<br> Content: Historical, current, and future trends for validating biological processes / R. Andrew Ramelmeier, Brian D. Kelley, and Christi Van Horn --<br/> Process characterization studies to facilitate validation of a recombinant protein fermentation / Jinyou Zhang, Jay Reddy, Peter Salmon, Barr
Biopharmaceutical Process Validation (Biotechnology and Bioprocessing)
โ Scribed by Gail Sofer
- Publisher
- Informa Healthcare
- Year
- 2000
- Tongue
- English
- Leaves
- 402
- Series
- Biotechnology and Bioprocessing Series
- Edition
- 1
- Category
- Library
No coin nor oath required. For personal study only.
โฆ Synopsis
Enables biopharmaceutical developers and producers to ensure safe products, reduce risk of adverse reactions in patients, and avoid recalls by outlining sophisticated validation approaches to characterizing processes, process intermediates, and final products, emphasizing cost effectiveness while determining what levels of validation are required for different phases of development, license application, and process improvements. Sofer is director of regulatory services at BioReliance. Zabriskie is director of biopharmaceutical process sciences at Biogen.
๐ SIMILAR VOLUMES
<P><STRONG>Process Validation in Manufacturing of Biopharmaceuticals, Third Edition</STRONG> delves into the key aspects and current practices of process validation. It includes discussion on the final version of the <EM>FDA 2011 Guidance for Industry on Process Validation Principles and Practices</
Bioprocessing: an exciting new engineering discipline. It combines the development and optimization of biotechnological processes with effective strategies to recover and purify the desired products. Safety as well as cost play an important role here. This volume covers the immensely differenti
Rathore, a scientist in process development, and Sofer, director of regulatory compliance at a biosciences firm, offer practical guidelines, recommendations, and an abundance of industrial case studies demonstrating various techniques and approaches in the validation of biopharmaceutical processes.